Dashboard
Manage Tickers

KDNY


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

benzingas-top-ratings-upgrades-downgrades-for-august-8-2023
Benzinga's Top Ratings Upgrades, Downgrade...
08/08/2023 15:00:33

wedbush-downgrades-chinook-therapeutics-to-neutral-announces-42-price-target
Wedbush Downgrades Chinook Therapeutics to...
08/08/2023 12:41:04

Wedbush analyst Laura Chico downgrades Chinook Therapeutics (NASDAQ:KDNY) from Outperform to Neutral and announces $42 price...

benzingas-top-ratings-upgrades-downgrades-for-august-1-2023
Benzinga's Top Ratings Upgrades, Downgrade...
08/01/2023 15:00:35

expert-ratings-for-chinook-therapeutics
Expert Ratings for Chinook Therapeutics
08/01/2023 12:00:21

wells-fargo-downgrades-chinook-therapeutics-to-equal-weight-raises-price-target-to-40
Wells Fargo Downgrades Chinook Therapeutic...
08/01/2023 10:29:29

Wells Fargo analyst Mohit Bansal downgrades Chinook Therapeutics (NASDAQ:KDNY) from Overweight to Equal-Weight and raises th...

chinook-therapeutics-announced-that-the-first-patient-with-iga-nephropathy-has-been-enrolled-in-the-beyond-phase-3-trial-of-evaluating-the-safety-and-efficacy-of-zigakibart-bion-1301-1301
Chinook Therapeutics Announced That The Fi...
07/28/2023 12:03:12

hc-wainwright--co-reiterates-neutral-on-chinook-therapeutics-maintains-40-price-target
HC Wainwright & Co. Reiterates Neutral on ...
06/21/2023 12:28:37

HC Wainwright & Co. analyst Ed Arce reiterates Chinook Therapeutics (NASDAQ:KDNY) with a Neutral and maintains $40 price...

Core News & Articles
Benzinga's Top Ratings Upgrades, Downgrade...
06/14/2023 15:01:57

evercore-isi-group-downgrades-chinook-therapeutics-to-in-line-announces-40-price-target
Evercore ISI Group Downgrades Chinook Ther...
06/14/2023 13:19:20

Evercore ISI Group analyst Josh Schimmer downgrades Chinook Therapeutics (NASDAQ:KDNY) from Outperform to In-Line and announ...

benzingas-top-ratings-upgrades-downgrades-for-june-13-2023
Benzinga's Top Ratings Upgrades, Downgrade...
06/13/2023 15:00:52

stifel-downgrades-chinook-therapeutics-to-hold-lowers-price-target-to-41
Stifel Downgrades Chinook Therapeutics to ...
06/13/2023 11:25:53

Stifel analyst Alex Thompson downgrades Chinook Therapeutics (NASDAQ:KDNY) from Buy to Hold and lowers the price target from...

svb-leerink-downgrades-chinook-therapeutics-to-market-perform-lowers-price-target-to-40
SVB Leerink Downgrades Chinook Therapeutic...
06/13/2023 10:16:35

SVB Leerink analyst Joseph Schwartz downgrades Chinook Therapeutics (NASDAQ:KDNY) from Outperform to Market Perform and lowe...

hc-wainwright--co-downgrades-chinook-therapeutics-to-neutral-announces-40-price-target
HC Wainwright & Co. Downgrades Chinook The...
06/13/2023 10:12:40

HC Wainwright & Co. analyst Ed Arce downgrades Chinook Therapeutics (NASDAQ:KDNY) from Buy to Neutral and announces $40 ...

chinook-therapeutics-to-present-updated-data-from-zigakibart-phase-12-trial-in-patients-with-iga-nephropathy-at-the-60th-european-renal-association-congress
Chinook Therapeutics To Present Updated Da...
06/12/2023 20:07:50

Zigakibart treatment continues to demonstrate rapid and sustained reductions in mechanistic biomarkers, including IgA and Gd-Ig...

nasdaq-gains-1-us-budget-deficit-widens-in-may
Nasdaq Gains 1%; US Budget Deficit Widens ...
06/12/2023 18:54:41

U.S. stocks traded higher toward the end of trading, with Nasdaq Composite gaining over 100 points on Monday. The Dow traded u...

Core News & Articles
12 Health Care Stocks Moving In Monday's I...
06/12/2023 17:31:37

why-asset-entities-shares-are-trading-higher-by-142-here-are-other-stocks-moving-in-mondays-mid-day-session
Why Asset Entities Shares Are Trading High...
06/12/2023 17:03:57

Gainers Asset Entities Inc. (NASDAQ: ASST) shares jumped 142% to $2.79 after the company announced the development of an AI ...

what-6-analyst-ratings-have-to-say-about-chinook-therapeutics
What 6 Analyst Ratings Have To Say About C...
06/12/2023 17:02:42

what-to-know-about-guggenheims-downgrade-of-chinook-therapeutics
What To Know About Guggenheim's Downgrade ...
06/12/2023 17:00:56

cantor-fitzgerald-downgrades-chinook-therapeutics-to-neutral-announces-40-price-target
Cantor Fitzgerald Downgrades Chinook Thera...
06/12/2023 16:43:53

Cantor Fitzgerald analyst Charles Robertson II downgrades Chinook Therapeutics (NASDAQ:KDNY) from Overweight to Neutral and ...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION